Upgrade to SI Premium - Free Trial

Form 3 Klarna Group plc For: Mar 17 Filed by: Neglen Niclas

March 17, 2026 11:11 AM
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person *
Neglen Niclas
(Last) (First) (Middle)
10 YORK ROAD
(Street)
LONDON X0 SE1 7ND
(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
03/17/2026 		3. Issuer Name and Ticker or Trading Symbol
Klarna Group plc [ KLAR ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
 5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Klarna Group plc Ordinary Shares 45,615 (1)
D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Larkan AB Restricted Stock Units (2) (2) Klarna Group plc Ordinary Shares (2) (2) D
Larkan SPV Warrants L4:1 09/01/2027 11/15/2027 Klarna Group plc Ordinary Shares 906,636 (3) 6,885.33 (10) D
Larkan SPV Warrants L4:2 09/01/2027 11/15/2027 Klarna Group plc Ordinary Shares 23,688 (4) 2,295.11 (10) D
Larkan SPV Warrant L5:1 09/01/2027 11/15/2027 Klarna Group plc Ordinary Shares 23,544 (5) 2,295.11 (10) D
Larkan SPV Warrant L5:2 09/01/2027 11/15/2027 Klarna Group plc Ordinary Shares 933,612 (6) 6,885.33 (10) D
Larkan SPV Warrant L11:3 09/01/2028 11/30/2028 Klarna Group plc Ordinary Shares 340,896 (7) 2,295.11 (10) D
Larkan SPV Warrants L11:3 09/01/2028 11/30/2028 Klarna Group plc Ordinary Shares 650,400 (8) 2,295.11 (10) D
Klarna Group plc Options 03/05/2026 09/05/2029 Klarna Group plc Ordinary Shares 423,504 (9) 748.5 (10) D
Klarna Group plc Options 03/05/2026 09/05/2029 Klarna Group plc Ordinary Shares 941,460 (9) 1,122.75 (10) D
Explanation of Responses:
1. In addition to the ordinary shares reported in this Form 3, the reporting person beneficially owns a number of the Klarna Group plcs (the Issuer) Class B shares. Each Class B share is entitled to 10 votes per share. Class B shares are not transferable and are not exchangeable for or convertible into ordinary shares.
2. Represents 14,569 restricted stock units in Larkan AB (Larkan), an indirect subsidiary of Klarna Group plc (the Issuer). Once shares of Larkan are delivered in settlement of the restricted stock units, approximately four shares of Larkan are convertible into one Klarna Group plc ordinary share (Shares). Restricted Stock Units in Larkan vest quarterly, at a total vesting of 25% of the initial grant per year.
3. Represents warrants to acquire 75,553 shares of Larkan IV AB, a direct subsidiary of the Issuer. Each underlying share of Larkan IV AB is convertible into approximately twelve Shares based on a formula set forth in the applicable award agreement, resulting in 906,636 Shares being subject to the warrant, that is vesting annually by 20% for a period of four years with an additional 20% vesting on August 27, 2027.
4. Represents warrants to acquire 1,974 shares of Larkan IV AB, a direct subsidiary of the Issuer. Each underlying share of Larkan IV AB is convertible into approximately twelve Shares based on a formula set forth in the applicable award agreement, resulting in 23,688 Shares being subject to the warrant, that is vesting annually by 20% for a period of four years with an additional 20% vesting on August 27, 2027.
5. Represents warrants to acquire 1,962 shares of Larkan V AB, a direct subsidiary of the Issuer. Each underlying share of Larkan V AB is convertible into approximately twelve Shares based on a formula set forth in the applicable award agreement, resulting in 23,544 Shares being subject to the warrant, that is vesting annually by 20% for a period of four years with an additional 20% vesting on August 27, 2027.
6. Represents warrants to acquire 77,801 shares of Larkan V AB, a direct subsidiary of the Issuer. Each underlying share of Larkan V AB is convertible into approximately twelve Shares based on a formula set forth in the applicable award agreement, resulting in 933,612 Shares being subject to the warrant, that is vesting annually by 20% for a period of four years with an additional 20% vesting on August 27, 2027.
7. Represents warrants to acquire 28,408 shares of Larkan XI AB, a direct subsidiary of the Issuer. Each underlying share of Larkan XI AB is convertible into approximately twelve Shares based on a formula set forth in the applicable award agreement, resulting in 340,896 Shares being subject to the warrant, that is vesting annually over four years in equal instalments.
8. Represents warrants to acquire 54,200 shares of Larkan XI AB, a direct subsidiary of the Issuer. Each underlying share of Larkan XI AB is convertible into approximately twelve Shares based on a formula set forth in the applicable award agreement, resulting in 650,400 Shares being subject to the warrant, that is vesting annually over four years in equal instalments.
9. Represents an option to acquire Shares that vest in four equal annual installments beginning on the first anniversary of the grant date.
10. This is in SEK.
Boudien Moerman, as attorney-in-fact 03/17/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Categories

SEC Filings